EGFR and head and neck cancer: Bernier et al. presented revised comprehensive consensus guidelines for RD in patients with head and neck cancer receiving epidermal growth factor receptor inhibitors in combination with radiotherapy and defined the degree of moist desquamation as the percentage within the irradiation fields28.